Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes

Psoma, Ourania; Papachristoforou, Eleftheria; Kountouri, Aikaterini; Balampanis, Konstantinos; Stergiou, Athena; Lambadiari, Vaia; Liatis, Stavros; Tsimihodimos, Vasilis

doi:10.1016/j.jdiacomp.2020.107756

Cited by 31 publications

(38 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similar findings were reported in China [15], Korea [16] and by another group in India [17]. In contrast, a separate study from India [18] and one from Greece [19] reported that glycemic control improved; nevertheless, it was reported as unchanged in studies from Italy [20,21] and Turkey [22].…”

Section: Introductionsupporting

confidence: 77%

“…Herein, we analyzed data collected until August 2020; therefore, the lack of change in BMI may be due to the short observation period. Previous studies on the impact of the COVID-19 pandemic on body weight in patients with diabetes mellitus were inconsistent, reporting an increase [7], no change [18,[21][22][23], and a decrease [19]. These previous studies also had short observation periods.…”

Section: Discussionmentioning

confidence: 99%

“…(1,164 patients) was the same as that observed between March and April 2019 (1,135 patients); meanwhile, the number of patients who requested telemedicine consultations was 30 (1.7%) in the present study sample. These findings suggest that the rate of measurements of HbA1c values at our clinic was not reduced during the pandemic, unlike in countries that imposed lockdowns [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23].…”

Section: Discussionmentioning

confidence: 99%

“…The coronavirus disease 2019 (COVID- 19) was first identified in Wuhan, China, in late 2019, before spreading worldwide [1]. The World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020 [2].…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown

Tanji

Sawada

Watanabe

et al. 2021

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

Aims Some studies have reported changes in glycemic control of patients with diabetes mellitus under lockdown. However, no previous study examined the impact of the pandemic on glycemic control in patients with diabetes in countries that did not introduce a lockdown such as Japan. This study aimed to assess changes in glycemic control during the pandemic in patients with type 2 diabetes treated at a Japanese clinic. Methods We conducted a historical cohort study, using electronic medical records of patients with type 2 diabetes who visited our clinic between January 2019 and August 2020. Differences in HbA1c values before and after the outbreak of COVID-19 were the primary outcome, examined using the linear mixed model. Results HbA1c values significantly increased from 7.45% to 7.53% after the state of emergency was introduced (n=1,009). Furthermore, a deterioration in HbA1c values was observed in particular among women, patients aged ≥ 65 years, those with body mass index of ≥ 25 kg/m 2 , and those that were not using insulin. Conclusions Glycemic control deteriorated in patients with type 2 diabetes during the pandemic even in a country without a national lockdown.

show abstract

Section: Introductionsupporting

confidence: 77%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown

Tanji

Sawada

Watanabe

et al. 2021

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

show abstract

“…This resulted in a significant worsening in BCVA and CRT in patients with DME, as well as in progression to active PDR in 30% of patients with severe NPDR and in 8.3% of patients with previously quiescent PDR. Our findings seem to be independent of glycemic control since diabetic patients were found to exhibit a small but significant improvement in glycemia, body weight, and total cholesterol while the other metabolic parameters remained stable [21].…”

Section: Discussionsupporting

confidence: 47%

Effect of COVID-19-Associated Lockdown on Patients With Diabetic Retinopathy

Chatziralli¹,

Dimitriou²,

Kazantzis³

et al. 2021

Cureus

View full text Add to dashboard Cite

To evaluate the effect of the coronavirus disease 2019 (COVID-19)-related lockdown in the management of patients with diabetic retinopathy (DR), including diabetic macular edema (DME), in a tertiary reference center in Greece. MethodsIn this retrospective study, we first compared the number of patients who were diagnosed with DR or DME in our clinic during the period of the lockdown and during the same period of the previous year. In addition, we included consecutive patients with DR or DME, who were followed up and treated regularly in our clinic and their appointments deferred due to lockdown, so as to compare the visual acuity, fundoscopy, and optical coherence tomography (OCT) findings prior to and post lockdown. ResultsDuring the lockdown period, there was a statistically significant decrease in patients with DR and DME as compared to the same period in the previous year. Regarding patients with previously diagnosed DME, there was a statistically significant worsening in their visual acuity and central retinal thickness after lockdown as compared to the last visit before lockdown (p<0.001 for both comparisons). Concerning patients diagnosed with DR and without DME before lockdown, 30% of patients with severe non-proliferative diabetic retinopathy (NDPR) and 8.3% of patients with quiescent proliferative DR (PDR) progressed to active PDR while four out of 107 patients (3.7%) developed DME during the lockdown. Multivariate regression analysis revealed that only the time interval between the last visit before lockdown and the first visit after the lockdown was associated with the best-corrected visual acuity (BCVA) change (p=0.017). ConclusionsThe COVID-19-related lockdown was related to the postponement in patient care, which resulted in significantly worse visual acuity outcomes in patients with DR.

show abstract

The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes

et al. 2022

View full text Add to dashboard Cite

Purpose The aim the study was to assess the impact of the lockdown due to COVID-19 on diabetes control. Methods The HbA1c value from a pre-lockdown visit (V1) from patients with diabetes was compared to the lockdown visit one (V2) after 3–5 months of its duration. Additional information on how the HbA1c changed and which variables can modify HbA1c during lockdown was also studied. Results Records from 65 patients (type 2 diabetes −96,9%) were eligible and revealed that: HbA1c was at the target in 60% of the patients at V2 compared to 40% at V1; HbA1c decreased and normalized in 19, but worsened in 4 participants during the lockdown. No impact on HbA1c of: sex, age, diabetes duration, therapy type and modification before the pandemic, abandonment of the treatment, previous problems with glycemic control, or change in body weight and physical activity during the lockdown, was found. The previous macrovascular complications were the only variable that affected the increase in HbA1c (p = 0.0072), OR = 5.33. Conclusions The COVID-19 pandemic has not revealed worsened glycemic control in patients with type 2 diabetes, in general. The patients with macrovascular complications turned out to be at risk of the harmful impact of the restrictions on the HbA1c.

show abstract

Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes

Cited by 31 publications

References 0 publications

Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown

Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown

Effect of COVID-19-Associated Lockdown on Patients With Diabetic Retinopathy

The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes

Contact Info

Product

Resources

About